Clearbridge Advisors LLC 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-09 5:23 pm Sale |
2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
Clearbridge Advisors LLC | 6,915,147 4.950% |
-1,032,429![]() (-12.99%) |
Filing |